DNA Vaccination Against Neuroblastoma

Clinical trial NCT04049864 · UNKNOWN

Trial details

NCT number: NCT04049864
Sponsor: Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed Neuroblastoma

Start date: 2019-01-09
Primary completion: 2023-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.